EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study

Oliver Kriege, Boris Böll, Nicole Brüder, Nicola Giesen, Julia Lanznaster, Susanne Mertins, Antrea Minti, Jan-Hendrik Naendrup, Martin Schmidt-Hieber, Ruth Seggewiss-Bernhardt, Philipp Weber, Kai Wille und 4 weitere

Infection · 2026-10 · 54 (5) · 2969-2975

DOI: 10.1007/s15010-026-02888-7 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Infection, online erschienen am 10.07.2026. Verfasst von Oliver Kriege und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, …. Hauptthemen laut MEDLINE: Catheter-Related Infections, Central Venous Catheters, Catheterization, Central Venous, Hematologic Neoplasms. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin der Johannes Gutenberg-Universität Mainz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

In patients with hematological malignancies and central venous catheters (CVC) men have a higher risk for CVC related bloodstream infections (CRBSI) than women. Hence, preventive strategies such as earlier CVC removal may reduce the overall CRBSI (oCRBSI) rate.

Methods

A randomized simulation using data from a CVC registry was performed. Data were derived from unselected patients with hematological or oncological diseases and a CVC. Patients were randomized to an experimental (EXP-G) or control group (CON-G). For the men in the EXP-G, one-day increments of an earlier CVC removal were simulated based on actual data and compared to men in the CON-G without simulation. The primary endpoint was oCRBSI rate.

Results

Underlying diseases were mainly hematological malignancies (87.3%). In the male patients with a median CVC in situ time of 13 days, the oCRBSI rate was 7.3% (103/1408), with 7.3% (53/729) in the EXP-G and 7.4% (50/679) in the CON-G. In the EXP-G, simulated shortening of CVC time by 1 day in men resulted in an oCRBSI rate of 5.2% compared with 7.4% in the CON-G ( p = 0.12). Shortening CVC time by 2 days led to an oCRBSI rate of 4% ( p = 0.008); the corresponding median CVC time was 11 days. A 3-day shortening further to 10 days reduced the oCRBSI rate to 2.7% ( p < 0.001). Women from the same registry showed a 3.3% (30/920) oCRBSI rate after 12 days.

Conclusion

In conclusion, shortening the CVC dwell time in men by 2 or 3 days, corresponding to a CVC duration of 10–11 days, reduces the CRBSI rate in men and mitigates the higher risk, compared to women. Clinical Trial Registration: SECRECY (Study to Evaluate Central Venous Catheter-related Infections in Hematology and Oncology) was registered within the German Clinical Trial Register (DRKS; no. DRKS00006551) on 29 September 2014.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catheter-Related InfectionsCentral Venous CathetersCatheterization, Central VenousHematologic NeoplasmsNeoplasmsHumansMaleMiddle AgedAgedFemaleTime FactorsAdultAged, 80 and over

Stichwörter der Autor:innen

Central venous catheterCentral venous catheter-related bloodstream infectionMale sexPreventionRemoval

Autor:innen und Institutionen

  • Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. oliver.kriege@unimedizin-mainz.de.
  • Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Department of Hematology, Oncology and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany.
  • Department of Internal Medicine II, Passau Hospital, Passau, Germany.
  • Department of Internal Medicine II, Schwarzwald - Baar - Klinikum, Villingen-Schwenningen, Germany.

Förderung

  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Zitieren

APA

Kriege, O., Böll, B., Brüder, N., Giesen, N., Lanznaster, J., Mertins, S., Minti, A., Naendrup, J. H., Schmidt-Hieber, M., Seggewiss-Bernhardt, R., Weber, P., Wille, K., Panse, J., Hentrich, M., Schalk, E., & SECRECY Investigators (2026). Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study. Infection, 54(5), 2969-2975. https://doi.org/10.1007/s15010-026-02888-7

Vancouver

Kriege O, Böll B, Brüder N, Giesen N, Lanznaster J, Mertins S, et al. Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study. Infection. 2026;54(5):2969-2975. doi:10.1007/s15010-026-02888-7

BibTeX
@article{Kriege2026,
  author = {Kriege, Oliver and Böll, Boris and Brüder, Nicole and Giesen, Nicola and Lanznaster, Julia and Mertins, Susanne and Minti, Antrea and Naendrup, Jan-Hendrik and Schmidt-Hieber, Martin and Seggewiss-Bernhardt, Ruth and Weber, Philipp and Wille, Kai and Panse, Jens and Hentrich, Marcus and Schalk, Enrico and SECRECY Investigators, SECRECY Investigators},
  title = {Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study},
  journal = {Infection},
  year = {2026},
  volume = {54},
  number = {5},
  pages = {2969--2975},
  doi = {10.1007/s15010-026-02888-7}
}
Kostenlos starten →